JP Morgan Private Wealth Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio IMUC Stock Details IMUC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-500	Closed	-$9K	–	1217
2015 Q2	$9K	Hold	500	–	–	﹤0.01%	1039
2015 Q1	$10K	Hold	500	–	–	﹤0.01%	1129
2014 Q4	$15K	Hold	500	–	–	﹤0.01%	1087
2014 Q3	$18K	Hold	500	–	–	﹤0.01%	1071
2014 Q2	$22K	Hold	500	–	–	﹤0.01%	885
2014 Q1	$24K	Buy	+500	New	+$24.5K	﹤0.01%	868

Other funds holding IMUC

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

JP Morgan Private Wealth Advisors's IMUC Position: Q3 2015 in Review

JP Morgan Private Wealth Advisors sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q3 2015, closing a stake of 500 shares — an estimated $9K sold.

JP Morgan Private Wealth Advisors first reported a position in IMUC in Q1 2014 and held it in 6 quarters. The position peaked at $24K in Q1 2014. 28 funds tracked by Wall St. Rank hold IMUC as of Q3 2015.

JP Morgan Private Wealth Advisors reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q3 2015 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 500 ImmunoCellular Therapeutics, Ltd. shares in Q3 2015, an estimated $9K.
JP Morgan Private Wealth Advisors first reported a position in ImmunoCellular Therapeutics, Ltd. in Q1 2014 and held it in 6 quarters.
JP Morgan Private Wealth Advisors's ImmunoCellular Therapeutics, Ltd. position peaked at $24K in Q1 2014.
28 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q3 2015.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2015, filed 5 Nov 2015.